Peptides have moved from bodybuilding forums to your group chat, and nobody involved seems entirely sure what they’re talking about. Critics call the grey market dangerous and proponents advocate for life-changing benefits. The choice on whether to take them is personal, and it should be an informed one.
This covers the GLP-1 side too, plus where the law is heading.
What are peptides?
Short chains of amino acids your body already makes, acting as signaling molecules. Think of them as text messages between your cells: heal this tissue, release that hormone, turn down inflammation, we’ve had enough to eat.
They’re generally shorter than proteins, from three amino acids up to around 100, and scientists have catalogued roughly 7,000 of them in the human body. Because your digestive system breaks them into amino acids, most peptide drugs are injected rather than swallowed.
This isn’t new medicine. Insulin is a peptide, isolated in 1921, and the FDA has approved around 100 peptide therapeutics since. GLP-1s are peptides too. So “peptides” covers everything from the most rigorously studied drugs in existence to compounds that have never been formally tested in a human.
Are they legal?
Yes, with an asterisk, and the asterisk is moving.
FDA-approved peptides like semaglutide, tirzepatide, tesamorelin, and PT-141 are prescription medications with full approval for specific uses. Everything else sits in a category labeled “research use only, not for human consumption.” They’re legal to manufacture, sell, and buy, and none of that means they’re approved for people.
An FDA advisory panel recently voted to recommend loosening restrictions on six peptides for compounding pharmacies, which would move them out of the grey market and into pharmacies with a prescription. The politics around it are live and loud, with a genuine showdown between the wellness industry, researchers, and regulators over how far to open the door.
If that sequence sounds familiar, it should. Medical marijuana followed the same arc: people used it off-label and underground for years, the usage generated real-world evidence, researchers eventually caught up, and the law moved last. Health outcomes shape legislation at least as often as legislation shapes health outcomes.
The honest caveat on that parallel: cannabis had centuries of human use behind it. Some of these peptides have animal data and not much else, and researchers who study them professionally are openly uneasy about people injecting research-grade compounds at home. The regulation is catching up. It hasn’t caught up yet.
How to get them
For GLP-1s, go through a provider. This is the well-studied end of the category and there’s no reason to improvise. There are several providers: Ro, Midi, RemedyMeds, Henry, and others. Collective is one of the newer ones, and pools members’ buying power to negotiate GLP-1 pricing directly from U.S. pharmacies, the same model Thrive Market used on organic groceries.
Your primary care doctor works too, though the wait and the insurance conversation are usually longer.
For perimenopause and menopause, Midi Health works specifically with women in this window and can talk through where peptides fit alongside hormone therapy.
For research-grade peptides (only if you understand the risks), sourcing is the entire ballgame. What to insist on: U.S.-based manufacturing, a cGMP-compliant facility, and independent third-party testing with a published Certificate of Analysis for the specific batch you’re buying. Try companies like Simple Peptides or Alpha Biologix.
One limit worth knowing: a COA confirms what’s in the vial. It doesn’t tell you the compound is safe, that your dose is right, or that anyone has studied what happens after year three. Purity and safety are separate questions.
For topical, peptide skincare is the zero-needle entry point, and Korean formulations have been doing this well and cheaply for years. Copper peptides and signal peptides in a serum carry none of the sourcing questions.
And genuinely, tell your doctor. Even if you’ve already decided. They can flag interactions with what you’re taking and tell you which labs to watch.
Which ones are there and what they do
Innerbody has a nice chart showcasing all the different therapeutic benefits but here’s the short version:
Weight loss: semaglutide, tirzepatide, tesamorelin
Muscle and recovery: sermorelin, ipamorelin, CJC-1295, BPC-157, TB4, collagen peptides
Longevity: sermorelin, ipamorelin, CJC-1295
Inflammation: BPC-157, TB4
Sleep: ipamorelin, CJC-1295
Beyond the chart, GHK-Cu for skin, PT-141 for libido, and glutathione round out the ones women ask about most.
Why women are using them
Weight loss. The obvious one, and the reason GLP-1s broke into the mainstream. Clinical trials are now testing them for heart disease, addiction, and Alzheimer’s, so the category is getting bigger than weight.
Menopause and perimenopause. This is where a lot of the interest is coming from. Declining estrogen affects body composition, sleep, recovery, skin, and libido all at once, and conventional care has historically been thin here.
PCOS. Insulin resistance sits at the center of PCOS for many women, which is exactly what GLP-1s act on. Increasingly a prescribed, supervised use rather than an experimental one.
Appearance. Skin, hair, body composition. The vanity reasons, which nobody needs to apologize for. Topicals are the low-risk version and where most people start.
Your call, made with the full picture
Peptides run a spectrum from FDA-approved and rigorously studied to barely researched and entirely experimental. Quality control is a real issue. And plenty of smart women are using them anyway, because they’re curious or because conventional medicine hasn’t solved the thing they’re trying to solve.
The regulation is moving faster than the science. Wherever you land, land there knowing which end of the spectrum you’re standing on.
This is informational and not medical advice. Talk to a provider before starting any injectable.
